The Neuropsychiatry Brief is Justin Ray's free weekly newsletter on LinkedIn. Each issue takes one development in brain science or psychiatric treatment and explains what it means in practice: how a new medication works, what a trial result does and does not show, and how that fits into real-world care. Topics range from muscarinic and glutamate-based treatments to psychedelic research, long-acting injectables, and the everyday decisions behind a good medication plan.
It is written for clients, families, and clinicians who want to understand the science without the jargon, by a psychiatric nurse practitioner who treats people every day. Reading it is a good way to keep up with the same research that shapes care at South Chesapeake Psychiatry.
Subscribe to The Neuropsychiatry Brief on LinkedIn
If you would like a sample of the kind of topic the Brief covers, start with these articles: the rise of osavampator in adjunctive depression treatment, what Psychiatric Times got right about Cobenfy, and psychoplastogens, plasticity, and depression treatment.
Schedule an appointment today to get diagnosed, receive a prescription, and continue your journey towards mental peace.
